AI assistant
Advanced Enzyme Technologies Limited — Regulatory Filings 2021
Dec 31, 2021
62369_rns_2021-12-31_dbf7c688-9d12-4a7f-b50a-d0ddae9a0f64.pdf
Regulatory Filings
Open in viewerOpens in your device viewer
December 31, 2021
BSE Limited P. J. Towers, Dalal Street, Mumbai-400 001 Scrip ID-540025
National Stock Exchange of India Ltd. Exchange Plaza, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E) Mumbai-400 051 Scrip Code-ADVENZYMES
Dear Sir/Madam,
Sub: Intimation of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015
We wish to inform you that pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst / Investor Meetings with the Company is as under:
| Company is as under: | ||
|---|---|---|
| Date | Interaction With | Type |
| January04, 2022 | Vallum Capital | Virtual, One-on-One |
Note: The aforesaid is subject to change. Changes may happen due to exigencies on the part of Fund/Company.
The aforesaid information is also being uploaded on the Company’s website.
You are requested to kindly take a note of the same.
Thanking you, Yours faithfully,
For Advanced Enzyme Technologies Limited
SANJAY Digitally signed by SANJAY PRAKASH PRAKASH BASANTANI BASANTANI Date: 2021.12.31 16:44:19 +05'30'
Sanjay Basantani
Company Secretary and Head – Legal